Kirk I. Erickson

This study identifies DNA methylation sites associated with cognitive function in early-stage hormone receptor-positive breast cancer patients using epigenome-wide association analyses.

The paper identifies mtDNA damage as a blood-based biomarker for Parkinson's disease, showing increased levels in early-stage patients and mutation carriers, suggesting its potential for patient stratification in clinical trials.